SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K/A
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
August 15, 2016
Date of Report
(Date of Earliest Event Reported)
PREMIER HOPKINS INTERNATIONAL CORPORATION
(Exact Name of Registrant as Specified in its Charter)
CORAL ISLAND ACQUISITION CORPORATION
(Former Name of Registrant as Specified in its Charter)
Delaware 000-55628 81-2141429
(State or other (Commission File Number) (IRS Employer
jurisdiction Identification No.)
of incorporation)
7610 Carroll Avenue, Suite 360
Takoma Park, Maryland 20912
(Address of principal executive offices) (zip code)
(301) 500-4607
(Registrant's telephone number, including area code)
215 Apolena Avenue
Newport Beach, California 92662
(Former Address of Principal Executive Offices)
This amendment clarifies the biographical information appearing in
the original filing of this Form 8-K.
ITEM 3.02 Unregistered Sales of Equity Securities
On August 16, 2016, Premier Hopkins International Corporation
(formerly Coral Island Acquisition Corporation) (the "Registrant" or
the "Company") issued 10,000,000 shares of its common stock pursuant to
Section 4(2) of the Securities Act of 1933 at par representing
95.2% of the total outstanding 10,500,000 shares of common stock
as follows:
10,000,000 Dr. Umarani Natesan
With the issuance of the stock and the redemption of 19,500,000 shares
of stock (discussed below), the Company effected a change in its control and
the new majority shareholder(s) elected new management of the Company. The
Company may develop its business plan by future acquisitions or mergers but
no agreements have been reached regarding any acquisition or other business
combination. The Company changed its name as part of the change in control.
If the Company makes any acquisitions, mergers or other business combination,
the Company will file a Form 8-K but until such time the Company
remains a shell company.
ITEM 5.01 Changes in Control of Registrant
On August 15, 2016, the following events occurred which resulted in a
change of control of the Registrant:
1. The Registrant redeemed an aggregate of 19,500,000 of the then
20,000,000 shares of outstanding stock at a redemption price of $.0001 per
share for an aggregate redemption price of $1950.
2. The then current officers and directors resigned.
3. New officer(s) and director(s) were appointed and elected.
The disclosure required by Item 5.01(a)(8) of Form 8-K was previously filed
with the Securities and Exchange Commission on Form 10-12G filed on May 2, 2016
as amended and supplemented by the information contained in this report.
The Registrant anticipates that it will develop, through acquisition of a
private company or development of its business plan, which anticipates the
development of medical teaching hospitals and corresponding university.
ITEM 5.02 Departure of Directors or Principal Officers;
Election of Directors
On August 15, 2016 the following events occurred:
James M. Cassidy resigned as the Registrant's president, secretary
and director.
James McKillop resigned as the Registrant's vice president and
director.
Dr. Umarani Natesan was named the director of the Registrant.
Dr. Umarani Natesan was appointed President, Secretary and
Treasurer of the Registrant.
Dr. Umarani Natesan serves as the officer and director of the
Registrant. Dr. Natesan has focused her career on medical education. In
2003, Dr. Natesan worked as Director at AMERI/American Medical Institute
in Bangalore, India. In 2006, she was promoted to Vice President of AMERI's
Global Operations. In 2009, she established AIMUCUC Centre for Medical
Science in the United States. From its small beginning with few international
medical graduates and medical students, AIMUCUC has developed to a large
operating institution with three centers providing training for several
hundred students. In 2011, Premier Hopkins/AIMUCUC acquired American
International Medical University and in 2015, Premier Hopkins signed an
acquisition agreement to acquire another medical school, Washington
Medical Science Institute ("WMSI"). WMSI holds accreditations and approvals
for a popular dual degree based MD/MPH program. WMSI also offers a popular
training program for graduate medical education.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunder duly authorized.
PREMIER HOPKINS INTERNATIONAL CORPORATION
Date: August 22, 2016
/s/ Dr. Umarani Natesan
President